A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV

NCT07698600 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV -1 Infection

Interventions

BIOLOGICAL: BNT168
OTHER: Placebo

Sponsor

BioNTech SE